Filter

71 - 80 of 157 Results

  • Resource Explains Litigation Challenging State Stay at Home Orders

    News Release

    A new KFF brief provides an overview of the legal basis for state stay at home orders in response to the coronavirus pandemic, as well as current legal challenges to these orders. Stay at home orders and other mandatory social distancing measures have received broad public support, but also have drawn some public protests.  Different stakeholders have brought at least 20 legal challenges claiming these orders violate the Constitution or state law. Most courts to…

  • New theGrio/KFF Survey Project Examines Diverse Views of Black Voters Heading into 2022 Midterm Election

    News Release

    7 in 10 Worry About Voter Suppression Interfering with a Fair and Accurate Count Allen Media Group’s African American-focused news, lifestyle, and entertainment platform theGrio and KFF today released a joint national survey examining the mood and views of Black voters, the only in-depth public survey this election cycle focused exclusively on this group, which has historically been a solid Democratic voting bloc but holds diverse views that often get overlooked in national polling. Coverage…

  • Analysis Reveals How Abortion Boosted Democratic Candidates in Tuesday’s Midterm Election

    News Release

    While inflation was clearly at the top of voters’ minds in this year’s midterm elections, the Supreme Court decision overturning Roe v. Wade played a significant role in motivating key voting blocs that likely contributed to the Democratic party’s stronger-than-expected performance, a new analysis of KFF’s supplemental questions on the Associated Press VoteCast survey of midterm voters. About four in ten (38%) voters overall said that the Supreme Court decision ending the constitutional right to an abortion had a…

  • Preventive Services Use Among People with Private Insurance Coverage

    Issue Brief

    This analysis of claims data estimates that six in ten people with private health insurance - or about 100 million people - used at least one preventive service covered without any out-of-pocket costs through a provision of the Affordable Care Act (ACA) in a typical year prior to the COVID-19 pandemic (2018). The provision that requires most private health plans to cover many preventive services without any cost-sharing for their enrollees is being challenged in…

  • Medication Abortion in a Post-Roe v. Wade America

    Event Date:
    Event

    On Wednesday, July 20th, a panel of experts joined series moderator Larry Levitt in a 45-minute discussion about the use and safety of medication abortion and the current and future policy and practical challenges for accessing it across the country.

  • KFF Health Tracking Poll July 2022: Inflation Tops Voters’ Priorities, But Abortion Access Resonates For Key Voting Blocs

    Feature

    This poll finds most voters (55%) now say access to abortion is “very important” to their vote in November’s midterm elections, up since the Supreme Court decision overturning Roe v. Wade. This heightened interest is greatest among voter groups who largely want to guarantee access to abortion, including Democratic voters and women voters under 50 years old.

  • SCOTUS Case Could Weaken the Impact of Regulation on Key Patient and Consumer Protections

    Issue Brief

    This brief discusses the longstanding legal doctrine, Chevron deference, being challenged in two cases before the U.S. Supreme Court and includes examples of what could be at stake for health care consumers should federal courts no longer use this doctrine to address litigation related to federal health regulations. The focus here is on patient and consumer protection regulation, but overturning the Chevron deference would have implications in all areas of health care.

  • The Supreme Court, Medication Abortion, and the FDA: What’s at Stake?

    News Release

    In advance of oral arguments about access to medication abortion before the Supreme Court on March 26, KFF examines how a Court ruling for the plaintiffs would limit access to mifepristone blocking its use in telehealth and distribution through pharmacies, including in states where abortion is legal and protected. In addition, it could potentially weaken the role of the Food and Drug Administration (FDA) in drug reviews—something the Court has never done before. As part…